Bit Bio

Reviews voor Bit Bio

Trying to run before they can walk - werkgeversreview Operations bij Bit Bio

2,0

1 mrt 2023

Operations

Aanbevelen

Goedkeuring directeur

Zakelijk vooruitzicht

Pluspunten

Senior Management have ambitious goals and vision and steam ahead without consideration for ensuring required infrastructure and support functions are in place and established which leads to unnecessary politics and stress.

Minpunten

Due to lack of infrastructure many personnel are working long hours and weekends trying to keep up with an overly ambitious program.

Reactie van Bit Bio

Thank you for taking the time to leave a review of bit.bio, and I'm sorry about your negative experience with us. We are an ambitious and fast-moving organisation, and recognise this and reward our employees accordingly. We regularly monitor working hours, and are pleased that this does not appear to be the case at present. We are recruiting to ensure we have the adequate resource, and offer many initiatives to support employees through our fast-paced environment, which we agree, isn't for everyone. We hope that you have found a suitable role and wish you the best in your new environment.

Ontdek andere reviews over Bit Bio

1,0

13 aug 2025

Scientist

Aanbevelen

Goedkeuring directeur

Zakelijk vooruitzicht

Pluspunten

Many scientists are highly skilled and dedicated to their work and most facilities are well-equipped

Minpunten

bit.bio used to be a good company with a strong mission, but the recent leadership changes have made it clear there is no stable strategy or direction. In just two months, the company went through three different CEOs — even governments don’t rotate leaders that fast. In both 2024 and 2025, roughly 20–30% of the workforce was made redundant. These cuts were followed almost immediately by hiring sprees and promotions at senior management level, which made little sense. Internal roles were often tailored to people already chosen to stay, and redundancy packages were inconsistent. What’s worse, company documents from as far back as November 2023 indicated financial instability, yet new hires were still brought on — some only to be let go within weeks or months. Promotions are almost exclusively for senior-level staff; research assistants, even those with 3–6 years of experience, remain stuck in the same role without salary reviews, and requests for progression are met with vague, dismissive explanations. The lack of strategic clarity is striking. For example, in 2024 the company invested in building a cell therapies department, only to make the entire team redundant within months, then shifted focus to commercial hiring, and now seems to be exploring media component development. The result is a constant feeling of uncertainty: offices are half-empty, morale is low, and employees feel undervalued. HR has also not helped the situation — redundancies were handled with minimal transparency and support, with packages kept to the bare minimum. Overall, bit.bio has gone from a place with real potential to one marked by instability, unclear priorities, and poor treatment of staff.

Reactie van Bit Bio

9mo

Thank you for taking the time to share your feedback. We’re glad you highlighted the dedication and expertise of our scientific teams and the strength of our facilities — these remain some of our greatest assets. We also want to acknowledge your concerns regarding leadership transitions and organisational changes. The past two years have been a very challenging time across the biotech sector, with many companies facing closures or significant restructuring. At bit.bio, we have had to make difficult decisions to secure the company’s future and focus resources where they will have the greatest long-term impact. Regarding redundancies, it is important to clarify that while HR plays a supporting role, these decisions are made at the executive level. HR’s responsibility is to ensure the process is carried out fairly, respectfully, and with support for those affected. These processes were conducted with transparency, and as much detail as could be shared at the time was communicated directly by the Executive team. Given the financial status of the organisation, we were unable to provide enhanced packages, but all statutory requirements were met. In addition, we offered LinkedIn learning training, CV and interview support, and proactively shared CVs with other organisations to help colleagues transition into new opportunities. We understand the impact such changes have on morale and on individuals personally. While these steps cannot take away the difficulty of redundancies, they reflect our commitment to supporting colleagues as best we can under the circumstances. bit.bio remains deeply committed to its mission of accelerating biomedical innovation through cell coding technology, and we continue to focus on building a sustainable path forward where employees feel valued and supported.

4,0

30 mrt 2026

Marketing manager

Aanbevelen

Goedkeuring directeur

Zakelijk vooruitzicht

Pluspunten

A growth company with fast paced environment bringing good exposure.

Minpunten

High volatility based on the funding environment

Reactie van Bit Bio

2mo

Thank you for your feedback. We're glad to hear that you’ve found value in the fast-paced, growth-oriented environment at bit.bio and the exposure it provides. We also appreciate your perspective on the challenges related to volatility in the funding environment. While this has been a factor in the past, we have since secured additional funding, which puts us in a more stable position. That said, we remain mindful of the responsibility that comes with this and are focused on deploying it thoughtfully to support our long-term goals and the sustainability of the business.

Bekijk reviews op: Nuttig|Beoordeling|Datum|Alle

Gerelateerde zoekopdrachten: Vacatures bij Bit Bio | Salarissen bij Bit Bio | Arbeidsvoorwaarden bij Bit Bio | Sollicitatiegesprekken van Bit Bio

Reviews voor Bit Bio Reviews voor Operations bij Bit Bio Review voor Bit Bio